Connection
Amy Amara to Carbamates
This is a "connection" page, showing publications Amy Amara has written about Carbamates.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.175 |
|
|
|
-
Videnovic A, Amara AW, Comella C, Schweitzer PK, Emsellem H, Liu K, Sterkel AL, Gottwald MD, Steinerman JR, Jochelson P, Zomorodi K, Hauser RA. Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial. Mov Disord. 2021 10; 36(10):2408-2412.
Score: 0.175